Adaptive Bayesian Design for Phase I Dose-Finding Trials Using a Joint Model of Response and Toxicity

By Wang Meihua  

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 1, 2010-01 ,pp. : 125-144

Taylor & Francis Ltd

Access to resources Recommend Favorite

Bayesian Optimal Adaptive Designs for Delayed-Response Dose-Finding Studies

By Li Wen  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 5, 2011-09 ,pp. : 888-901

Taylor & Francis Ltd

Access to resources Recommend Favorite

Design Issues in Dose-Finding Phase I Trials for Combinations of Two Agents

By Fan Shenghua Kelly  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 509-523

Taylor & Francis Ltd

Access to resources Recommend Favorite

Continual Reassessment Method vs. Traditional Empirically Based Design: Modifications Motivated by Phase I Trials in Pediatric Oncology by the Pediatric Brain Tumor Consortium

By Onar Arzu   Kocak Mehmet   Boyett James  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 437-455

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Bayesian Case Study in Oncology Phase I Combination Dose-Finding Using Logistic Regression with Covariates

By Bailey Stuart  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 469-484

Taylor & Francis Ltd

Access to resources Recommend Favorite